DrugDashboards

Fesoterodine Fumarate

Fesoterodine Fumarate · FESOTERODINE FUMARATE 8 mg/1 · Tablet, Extended Release · Oral · Alembic Pharmaceuticals Inc.

NDC 62332-0176-10 · 100 TABLET, EXTENDED RELEASE in 1 CARTON · ANDA · View full market →

The short version

7 companies supply this market — a reasonable cushion if one runs into trouble.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for fesoterodine fumarate (oral solid) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA204973
TE code
AB
Approval date
Jan 4, 2023
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class III · OngoingDec 16, 2025
    Alembic Pharmaceuticals Limited — Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit.
  • Class III · OngoingOct 10, 2025
    Alembic Pharmaceuticals Limited — Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit.

Manufacturers of Fesoterodine Fumarate (Tablet, Extended Release)

LabelerStrengthFirst seenLast seen
Aesica Pharmaceuticals GmbHFESOTERODINE FUMARATE 4 mg/1Jul 15, 2026Sep 2, 2026
Aesica Pharmaceuticals GmbHFESOTERODINE FUMARATE 8 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.FESOTERODINE FUMARATE 4 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.FESOTERODINE FUMARATE 8 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedFESOTERODINE FUMARATE 4 mg/1Jul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedFESOTERODINE FUMARATE 8 mg/1Jul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals LLCFESOTERODINE FUMARATE 4 mg/1Jul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals LLCFESOTERODINE FUMARATE 8 mg/1Jul 15, 2026Sep 2, 2026
Ascend Laboratories, LLCFESOTERODINE FUMARATE 4 mg/1Jul 15, 2026Sep 2, 2026
Ascend Laboratories, LLCFESOTERODINE FUMARATE 8 mg/1Jul 15, 2026Sep 2, 2026
Dr.Reddy's Laboratories Inc.,FESOTERODINE FUMARATE 4 mg/1Jul 15, 2026Sep 2, 2026
Dr.Reddy's Laboratories Inc.,FESOTERODINE FUMARATE 8 mg/1Jul 15, 2026Sep 2, 2026
Golden State Medical Supply, Inc.FESOTERODINE FUMARATE 4 mg/1Jul 15, 2026Sep 2, 2026
Golden State Medical Supply, Inc.FESOTERODINE FUMARATE 8 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Fesoterodine Fumarate — NDC 62332-0176-10," retrieved September 3, 2026, https://drugdashboards.com/drug/62332017610.

Free to cite with attribution — see how the data is put together.